Sign Up Today and Learn More About Capstan Therapeutics Stock
Invest in or calculate the value of your shares in Capstan Therapeutics or other pre-IPO companies through EquityZen's platform.
![Capstan Therapeutics](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/capstantherapeutics_logo-d7ab0d52665f35a4.png)
Capstan Therapeutics Stock
Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.
About Capstan Therapeutics Stock
Founded
2021
Headquarters
San Diego, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Capstan Therapeutics Press Mentions
Stay in the know about the latest news on Capstan Therapeutics
Capstan Therapeutics’ Post
linkedin • Aug 02, 2024
Capstan Therapeutics to Participate in 45th Annual Goldman Sachs Global Healthcare Conference
finance • Jun 25, 2024
Capstan Therapeutics Announces $175M Oversubscribed Series B Financing
finance • Jun 25, 2024
Johnson & Johnson, Pfizer, Eli Lilly and other big pharmas are backing this San Diego biotech with $175M
sandiegouniontribune • Jun 25, 2024
Capstan Therapeutics Appoints Ramin Farzaneh-Far, M.D., as Chief Medical Officer and Announces Key Business ...
finance • May 23, 2024
Capstan Therapeutics Management
Leadership team at Capstan Therapeutics
Director
Athena Countouriotis
Chief Technology Officer
Priya Karamali
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- Capstan Therapeutics current valuation
- Capstan Therapeutics stock price
- Available deals in Capstan Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Capstan Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Capstan Therapeutics through EquityZen funds. These investments are made available by existing Capstan Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Capstan Therapeutics stock?
Shareholders can sell their Capstan Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."